Provided by Tiger Trade Technology Pte. Ltd.

InspireMD

0.7899
+0.01001.28%
Post-market: 0.7505-0.0394-4.99%17:13 EDT
Volume:31.96K
Turnover:24.99K
Market Cap:36.72M
PE:-1.22
High:0.8099
Open:0.8000
Low:0.7652
Close:0.7799
52wk High:2.57
52wk Low:0.6300
Shares:46.49M
Float Shares:25.94M
Volume Ratio:0.73
T/O Rate:0.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6464
EPS(LYR):-0.7584
ROE:-202.81%
ROA:-85.85%
PB:1.17
PE(LYR):-1.04

Loading ...

InspireMD Announces 30-Day Results From the Cguardians Ii Clinical Trial of the Cguard Prime 80 Cm Implant for Use in Tcar Procedures

THOMSON REUTERS
·
Jun 11

InspireMD Announces First Patient Enrolled in the Cguardians Iii Pivotal Study of the Switchguard Neuro Protection System for Use in Tcar Procedures

THOMSON REUTERS
·
Jun 08

InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures

GlobeNewswire
·
Jun 08

InspireMD Shareholders Approve Stock Increase and Board Slate

TIPRANKS
·
Jun 04

InspireMD shareholders approve increase in authorized common shares to 250 million

Reuters
·
Jun 04

InspireMD director Paul Stuka acquires 20,000 common shares valued at $17,500

Reuters
·
May 30

InspireMD chair Paul Stuka to retire, won’t seek board reelection in 2027

Reuters
·
May 23

Top InspireMD Executive Makes Notable Move With Latest Stock Sale

TIPRANKS
·
May 22

InspireMD director Paul Stuka buys USD 17,325 common shares

Reuters
·
May 16

Top Executive Makes Bold Move With Fresh InspireMD Stock Purchase

TIPRANKS
·
May 14

InspireMD CEO Marvin Slosman acquires 21,000 shares valued at $25,200

Reuters
·
May 14

InspireMD director Paul Stuka buys common shares worth $87,125.56

Reuters
·
May 13

InspireMD Balances Fast Growth With U.S. Setback

TIPRANKS
·
May 11

Insiders Make Bold Moves as InspireMD Directors Load Up on Shares

TIPRANKS
·
May 09

InspireMD director Scott R. Ward acquires common shares worth $102,125

Reuters
·
May 09

InspireMD director Paul Stuka acquires 7,895 shares worth $9,053.79

Reuters
·
May 09

InspireMD director Gary S. Roubin acquires $106,200 in common shares

Reuters
·
May 09

InspireMD Q1 FY26 net loss widens 22.6% to $13.69 million; revenue more than doubles to $3.4 million

Reuters
·
May 07

InspireMD to Participate in Upcoming Bank of America Securities 2026 Global Healthcare Conference

GlobeNewswire
·
May 07

InspireMD Price Target Cut to $3.00/Share From $4.00 by Piper Sandler

Dow Jones
·
May 06